Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher
tabling member	label

Search

1125739

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	09/05/2019
	date tabled	09/05/2019
	ddp created	09/05/2019 17:01:22
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	09/05/2019 17:10:42 17/05/2019 13:06:04
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	252468
	legislature	25259
	parliament number	57
	question first answered	17/05/2019 12:34:07
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has plans to involve patient organisations in setting the success factors for the 2019 Voluntary Scheme for Branded Medicines Pricing and Access as part of the first operational review meeting.
	session	2017/19
	session number	1
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	title	House of Commons Tabled Parliamentary Question 2017/19 252468
	type	WrittenParliamentaryQuestion
	uin	252468
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	151 label Biography information for Tom Brake
	publisher	25259
	tabling member	151 label Biography information for Tom Brake

1127772

	human indexable
	published
	registered interest
	answer date	23/05/2019
	date	21/05/2019
	date tabled	21/05/2019
	ddp created	21/05/2019 17:40:30
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	21/05/2019 17:55:35 30/05/2019 11:24:02
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	257056
	legislature	25259
	parliament number	57
	question first answered	30/05/2019 10:52:06
	question text	To ask the Secretary of State for Health and Social Care, whether the review of the methods for the NICE Technology Appraisal Programme referred to in the 2019 voluntary scheme for branded medicines pricing and access will include support for earlier patient access to innovative medicines.
	session	2017/19
	session number	1
	tabling member constituency	Bolton West
	tabling member printed	Chris Green
	title	House of Commons Tabled Parliamentary Question 2017/19 257056
	type	WrittenParliamentaryQuestion
	uin	257056
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4398 label Biography information for Chris Green
	publisher	25259
	tabling member	4398 label Biography information for Chris Green

1132140

	human indexable
	published
	registered interest
	answer date	18/06/2019
	date	13/06/2019
	date tabled	13/06/2019
	ddp created	13/06/2019 17:16:35
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	13/06/2019 17:32:16 18/06/2019 17:11:01
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	264409
	legislature	25259
	parliament number	57
	question first answered	18/06/2019 16:39:17
	question text	To ask the Secretary of State for Health and Social Care, what progress NHS England has made on developing a commercial framework in relation to the Voluntary Pricing and Access Scheme for branded medicines.
	session	2017/19
	session number	1
	tabling member constituency	Newton Abbot
	tabling member printed	Anne Marie Morris
	title	House of Commons Tabled Parliamentary Question 2017/19 264409
	type	WrittenParliamentaryQuestion
	uin	264409
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4249 label Biography information for Anne Marie Morris
	publisher	25259
	tabling member	4249 label Biography information for Anne Marie Morris

1139442

	human indexable
	published
	registered interest
	answer date	22/07/2019
	date	16/07/2019
	date tabled	16/07/2019
	ddp created	16/07/2019 18:34:38
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/07/2019 18:43:37 22/07/2019 16:18:06
	hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
	house id	1
	identifier	277757
	legislature	25259
	parliament number	57
	question first answered	22/07/2019 15:46:12
	question text	To ask the Secretary of State for Health and Social Care, with reference to the 2019 Voluntary Scheme for Branded Medicines Pricing and Access, how many opportunities there have been for pharmaceutical industry trade bodies to input into NHS England’s commercial framework; and what steps the Government is taking to secure the participation of industry trade bodies.
	session	2017/19
	session number	1
	tabling member constituency	Cambridge
	tabling member printed	Daniel Zeichner
	title	House of Commons Tabled Parliamentary Question 2017/19 277757
	type	WrittenParliamentaryQuestion
	uin	277757
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4382 label Biography information for Daniel Zeichner
	publisher	25259
	tabling member	4382 label Biography information for Daniel Zeichner

1127674

	human indexable
	published
	registered interest
	answer date	22/05/2019
	date	20/05/2019
	date tabled	20/05/2019
	ddp created	20/05/2019 21:03:59
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	20/05/2019 21:13:50 29/05/2019 11:35:02
	hansard heading	Vegetables: Children
	house id	1
	identifier	256416
	legislature	25259
	parliament number	57
	question first answered	29/05/2019 11:03:20
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage children to eat green vegetables.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 256416
	type	WrittenParliamentaryQuestion
	uin	256416
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4131 label Biography information for Jim Shannon
	publisher	25259
	tabling member	4131 label Biography information for Jim Shannon

1126030

	human indexable
	published
	registered interest
	answer date	16/05/2019
	date	13/05/2019
	date tabled	13/05/2019
	ddp created	13/05/2019 18:25:28
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	13/05/2019 18:35:39 16/05/2019 16:18:02
	hansard heading	Vaccination: Children
	house id	1
	identifier	253521
	legislature	25259
	parliament number	57
	question first answered	16/05/2019 15:46:15
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that parents are given adequate advice and information on vaccination programmes.
	session	2017/19
	session number	1
	tabling member constituency	Newcastle-under-Lyme
	tabling member printed	Paul Farrelly
	title	House of Commons Tabled Parliamentary Question 2017/19 253521
	type	WrittenParliamentaryQuestion
	uin	253521
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	1436 label Biography information for Paul Farrelly
	publisher	25259
	tabling member	1436 label Biography information for Paul Farrelly

1126194

	human indexable
	published
	registered interest
	answer date	15/05/2019
	date	13/05/2019
	date tabled	13/05/2019
	ddp created	13/05/2019 18:33:04
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	13/05/2019 18:43:06 21/05/2019 16:53:01
	hansard heading	Urinary Tract Infections: Medical Treatments
	house id	1
	identifier	253693
	legislature	25259
	parliament number	57
	question first answered	21/05/2019 16:21:41
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the efficacy of Professor James Malone-Lee's approach to treating urinary tract infections.
	session	2017/19
	session number	1
	tabling member constituency	Tooting
	tabling member printed	Dr Rosena Allin-Khan
	title	House of Commons Tabled Parliamentary Question 2017/19 253693
	type	WrittenParliamentaryQuestion
	uin	253693
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4573 label Biography information for Dr Rosena Allin-Khan
	publisher	25259
	tabling member	4573 label Biography information for Dr Rosena Allin-Khan

1127168

	human indexable
	published
	registered interest
	answer date	20/05/2019
	date	16/05/2019
	date tabled	16/05/2019
	ddp created	16/05/2019 16:43:10
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/05/2019 16:51:26 22/05/2019 14:58:01
	hansard heading	Urinary Tract Infections
	house id	1
	identifier	255355
	legislature	25259
	parliament number	57
	question first answered	22/05/2019 14:26:35
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce unplanned hospital admissions resulting from urinary tract infections.
	session	2017/19
	session number	1
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	title	House of Commons Tabled Parliamentary Question 2017/19 255355
	type	WrittenParliamentaryQuestion
	uin	255355
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4523 label Biography information for Catherine West
	publisher	25259
	tabling member	4523 label Biography information for Catherine West

1127170

	human indexable
	published
	registered interest
	answer date	20/05/2019
	date	16/05/2019
	date tabled	16/05/2019
	ddp created	16/05/2019 16:43:15
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/05/2019 16:51:31 22/05/2019 15:00:07
	hansard heading	Urinary Tract Infections
	house id	1
	identifier	255357
	legislature	25259
	parliament number	57
	question first answered	22/05/2019 14:28:15
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to improve the (a) reporting and (b) tracking of urinary tract infections in the NHS; and if he will make a statement.
	session	2017/19
	session number	1
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	title	House of Commons Tabled Parliamentary Question 2017/19 255357
	type	WrittenParliamentaryQuestion
	uin	255357
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4523 label Biography information for Catherine West
	publisher	25259
	tabling member	4523 label Biography information for Catherine West

1136342

	human indexable
	published
	registered interest
	answer date	08/07/2019
	date	02/07/2019
	date tabled	02/07/2019
	ddp created	02/07/2019 20:00:54
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	02/07/2019 20:09:38 08/07/2019 16:37:03
	hansard heading	Tonsils: Health Services
	house id	1
	identifier	272271
	legislature	25259
	parliament number	57
	question first answered	08/07/2019 16:05:05
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of CCGs and NHS trusts setting higher thresholds for NHS treatment of tonsillitis than for private treatment.
	session	2017/19
	session number	1
	tabling member constituency	St Helens North
	tabling member printed	Conor McGinn
	title	House of Commons Tabled Parliamentary Question 2017/19 272271
	type	WrittenParliamentaryQuestion
	uin	272271
	version	1
	written parliamentary question type	NamedDay
	answer	answer
	creator	4458 label Biography information for Conor McGinn
	publisher	25259
	tabling member	4458 label Biography information for Conor McGinn